Fingerprint
Dive into the research topics of 'A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease
Jo Howard*, Claire Jane Hemmaway, Paul Telfer, D. Mark Layton, John Porter, Moji Awogbade, Timothy Mant, Daniel D. Gretler, Kobina Dufu, Athiwat Hutchaleelaha, Mira Patel, Vincent Siu, Sandra Dixon, Noel Landsman, Margaret Tonda, Joshua Lehrer-Graiwer
*Corresponding author for this work
- GSTT Guy's and St Thomas' NHS Foundation Trust
- Division of Cancer Studies
- King's College London
- Queen’s Hospital
- Barts and The London Queen Mary's School of Medicine and Dentistry
- Hammersmith Hospital
- UCL University College London
- King's College Hospital
- IQVIA Incorporated.
- Independent Drug Development Consultant
- Global Blood Therapeutics
Research output: Contribution to journal › Article › peer-review
88
Citations
(Scopus)